Quo vadis haemapheresis: Current developments in haemapheresis

Transfusion and Apheresis Science

Volumn 34, Issue 1, 2006, Pages 51-73

  Borberg, Helmut ^a  

^a Deutsches Haemapherese Zentrum   (Germany)

Author keywords

Apheresis history; Cell therapy; Cytapheresis; LDL apheresis; Lp(a) apheresis; Photopheresis; Rheohaemapheresis; Sepsis therapy; Stem cells

Indexed keywords

ANTIBODY; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CANCER VACCINE; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5 ANTIBODY; CORTICOSTEROID; DENDRITIC CELL VACCINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 ANTIBODY; ENDOTOXIN; ENDOTOXIN ANTIBODY; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; IBUPROFEN; IMMUNOGLOBULIN; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR; KETOCONAZOLE; KETOPROFEN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE ANTIBODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PENTOXIFYLLINE; PROTEIN C; PROTEINASE INHIBITOR; RETROVIRUS VECTOR; SOLUBLE INTERLEUKIN 1 RECEPTOR; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ADSORPTION; APHERESIS; ARTIFICIAL LIVER; BLOOD RHEOLOGY; CANCER; CELL SEPARATION; CENTRIFUGATION; CLINICAL TRIAL; CONFERENCE PAPER; COST BENEFIT ANALYSIS; CYTAPHERESIS; DETOXIFICATION; DISEASE CONTROL; ECONOMIC ASPECT; ERYTHROCYTAPHERESIS; ERYTHROCYTE; EVIDENCE BASED MEDICINE; FAMILIAL HYPERCHOLESTEROLEMIA; FILTRATION; GENE TRANSFER; GRANULOCYTAPHERESIS; GRANULOCYTE; GRANULOCYTE TRANSFUSION; HUMAN; IMMUNOPATHOLOGY; INTERMETHOD COMPARISON; LEUKAPHERESIS; LEUKEMIA; LIPOPROTEIN A APHERESIS; LOW DENSITY LIPOPROTEIN APHERESIS; LYMPHOCYTAPHERESIS; LYMPHOCYTE; LYMPHOCYTE TRANSFUSION; MEMBRANE FILTER; MICROANGIOPATHY; MONOCYTAPHERESIS; MONOCYTE; NEUTROPENIA; NONHUMAN; ONLINE MONITORING; PLASMAPHERESIS; POLYCYTHEMIA VERA; PRECIPITATION; PUVA; QUALITY CONTROL; RHEOHEMAPHERESIS; SEPSIS; SEPTICEMIA; SOLID TUMOR; STEM CELL; STEM CELL CYTAPHERESIS; STEM CELL TRANSPLANTATION; TISSUE REPAIR; TREATMENT INDICATION; TREATMENT WITHDRAWAL; VIRAL GENE DELIVERY SYSTEM;

ADSORPTION; ADULT; AGED; BLOOD COMPONENT REMOVAL; BLOOD TRANSFUSION; ERYTHROCYTES; FEMALE; FILTRATION; GENE THERAPY; GRANULOCYTES; HEMODILUTION; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNE SYSTEM DISEASES; LEUKAPHERESIS; LEUKOCYTES; LIPOPROTEINS, LDL; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; PLASMAPHERESIS; QUALITY CONTROL; QUALITY OF LIFE; SEPSIS; TIME FACTORS;

EID: 32344433168     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2005.11.001     Document Type: Conference Paper

References (339)

1. E.J. Freireich, G. Judson, and R.H. Levin Separation and collection of leukocytes Cancer Res 25 1965 1516 1520
2. G. Judson, A. Jones, D. Kellogg, D. Buckner, R. Eisel, and S. Perry Closed continuous flow centrifuge Nature 217 1968 816 820
3. J.L. Tullis, R.J. Tinch, J.G. Gibson, and P. Bandanza A simplified centrifuge for the separation and processing of blood cells Transfusion 7 1967 232 240
4. I.O. Szymanski, K. Patti, and A. Kliman Efficacy of the Latham blood processor to perform plateletpheresis Transfusion 13 1973 405 411
5. Y. Ito, and K. Shinomiya A new continuous flow separation method based on cell density: principle, apparatus, and preliminary application to separation of human buffy coat J Clin Apher 16 2001 186 191
6. N. Yui, K. Samui, N. Ogata, K. Kataoka, T. Okano, and Y. Sakurai Reversibility of granulocyte adhesion using polyamine-grafted nylon-6? new column substrate for granulocyte separation Biomaterials 6 6 1985 409 415
7. J. Shibusawa Surface affinity chromatography of human peripheral blood cells J Chromatogr B Biomed Sci Appl 722 1-2 1999 71 88
8. J. Shibusawa Separation and retention of human blood cells by surface affinity chromatography J Biochem Biophys Methods 49 1-3 2001 683 703
9. A. Kawamura, M. Saitoh, M. Yonekawa, T. Horie, H. Ohizumi, and T. Tamaki New technique of leukocytapheresis by the use of nonwoven polyester filter for inflammatory bowel disease Ther Apher 3 4 1999 334 337
10. K. Yamayi, H. Tsuda, and H. Hashimoto Current topics on cytapheresis technologies Ther Apher 5 4 2001 287 292
11. J. Shirokaze Leukocytapheresis using a leukocyte removal filter Ther Apher 6 4 2002 261 266
12. R. Dowling, V. Weber, L. Osborne, and H. Klein Mononuclear cell collection using various techniques J Clin Apheresis 2 1 1984 32 40
13. A. Faradji, A. Bohbot, M. Schmitt-Goguel, J.C. Siffert, S. Dumont, and M.L. Wi Large scale isolation of human blood monocytes by continuous flow centrifugation leuk apheresis and counterflow centrifugal elutriation for adoptive cellular immunotherapy of cancer patients J Immunol Methods 174 1-2 1994 297 309
14. L.J. Zhou, and Th.F. Tedder CD 14+ blood monocytes can differentiate into functionally mature CD 83+ dendritic cells Proc Natl Acad Sci (USA) 93 1996 2588 2592
15. R.L. Edelson Extracorporeal photopheresis Trans Am Soc Artif Intern Organs 30 1984 674 675
16. F. Schooneman Extracorporeal photopheresis technical aspects Transfus Apher Sci 28 2003 51 61
17. G. Andreu, A. Leon, F. Heshmati, M. Tod, C.J. Menkes, and J. Baudelot Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders Transfu Sci 15 4 1994 443 454
18. Schreiner T. Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of three cases. In: 14th Congress of the ESfH, Abstract L 14.
19. M. Valbonesi, R. Frisoni, G. Florio, M.R. Ruzzenenti, C. Capra, and M. Merlo Single-donor platelet concentrates produced along with packed red blood cells with the Haemonetics MCS 3p: preliminary results J Clin Apher 9 3 1994 195 199
20. D.H. Whitman, R.L. Berry, and D.M. Green Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery J Oral Maxillofac Surg 55 1997 1294 1297
21. D.M. Green, and B. Klink Platelet gel as an intraoperatively procured platelet based alternative to fibrin glue Plast Reconst Surg 101 1998 1161 1166
22. R.F. Reiss, and M.C. Oz Autologous fibrin glue: production and clinical use Transfus Med Rev X 2 1996 85 92
23. G. Rock, R. Berger, J. Lange, M. Tokessy, D.S. Palmer, and A. Giulivi A novel automated method of temperature cycling to produce cryoprecipitate Transfusion 41 2001 232 235
24. T. Agishi, M. Chikamori, T. Suzuki, K. Ota, H. Amemiya, and N. Sugino Effect of double filtration plasmapheresis on peripheral circulation T. Oda Therapeutic plasmapheresis I 1981 F.K. Schattauer 119 124
25. M. Takamori, S. Okumura, and Y. Ide A synthetic peptide, Torpedo californica alpha 183-200 of the acetylcholine receptor as a tool for immunoadsorption via plasma perfusion in myasthenia gravis Artif Organs Today 1 1991 53 60
26. M. Takamori, T. Hamada, and S. Okumura Myasthenogenicity in the main immunogenic region of acetylcholine receptor as modified by conformational design: an approach to antigenic synthetic peptides J Neurol Sci 109 1992 182 187
27. M. Takamori, and S. Okumura Specific removal of anti-acteylcholine receptor antibodies in patients with myasthenia gravis Transfus Sci 17 1996 445 453
28. G. Wallukat, J. Müller, and R. Hetzer Specific removal of beta 1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy N Engl J Med 347 22 2002 1806
29. W. Rönspeck, R. Brinckmann, R. Egner, F. Gebauer, D. Winkler, and P. Jekow Peptide based adsorbers for therapeutic immunoadsorption Ther Apher Dial 7 1 2003 91 99
30. Jimenez-Klingberg C. IgG immune apheresis: a newly developed sytem. The young investigators award. In: 4th International congress of the World Apheresis Association, Sapporo, 3-5 June 1992.
31. Borberg H, Jimenez-Klingberg C. Selective adsorption of immunoglobulin G: a comparison of a new type adsorber with protein A and tryptophane conjugated polyvinylalcohol gel columns. In: 4th International congress of the World Apheresis Association, Sapporo, 3-5 June 1992, Abstract 111.
32. C. Jimenez-Klingberg, M. Belak, and P. Späth Selective adsorption of cryoglobulins from plasma of three patients with mixed type II cryoglobulinemia Beitr Infusionsther Transfus 32 1994 370 373
33. R.C. Ventura, R.L. Zollner, C. Legallais, M. Vijayalakshmi, and S.M. Bueno In vitro removal of human IgG autoantibodies by affinity filtration using immobilized l-histidine onto PEVA hollow fiber membranes Biomol Eng 17 2 2001 71 74
34. H. Kutsuki, S. Takata, K. Yamamoto, and N. Tani Therapeutic selective adsorption of anti-DNA antibody using dextran sulfate cellulose column (Selesorb) for the treatment of systemic lupus erythematosus Ther Apher 2 1 1998 18 24
35. K. Suzuki, M. Shimazaki, and H. Kutsui ß2-Microglobulin selective adsorber column (Lixelle) for the treatment of dialysis related amyloidosis Ther Apher Dial 7 1 2003 104 107
36. T. Asahi, T. Yamamoto, and H. Kutsuki Blood purification therapies using dextran sulfate cellulose columns Liposorber and Selesorb Ther Apher Dial 7 1 2003 73 77
37. Borberg H. Unpublished observations.
38. W.G. Zoller, H. Kellner, and F.A. Spengel Erythrocytapheresis. A method for rapid extracorporeal elimination of erythrocytes Klin Wschr 66 9 1988 404 409
39. U. Kaboth, K.W. Rumpf, T. Lipp, J. Bigge, M. Nauck, and J.H. Beyer Treatment of polycythaemia vera by isovolemic large-volume erythrocytapheresis Klin Wschr 68 1 1990 18 25
40. U. Kaboth, K.W. Rumpf, T. Liersch, K. Vehmeyer, D. Krieter, and W. Kaboth Advantages of isovolaemic large-volume erythrocytapheresis as a rapidly effective and long- lasting treatment modality for red blood cell depletion of patients with polythemia vera Ther Apher 1 2 1997 131 134
41. K.M. Grima Therapeutic apheresis in hematological and oncological diseaes J Clin Apheresis 15 1-2 2000 28 52
42. A. Kohan, R. Niborski, J. Daruich, J. Rey, F. Bastos, and G. Amerise Erythrocytapheresis with recombinant human erythropoietin in hereditary haemochromatosis therapy: a new alternative Vox Sang 79 1 2000 40 45
43. M. Valbonesi, and R. Bruni Clinical application of therapeutic erythrocytapheresis (TEA) Transfus Sci 22 3 2000 183 194
44. J. Muncunill, P. Vaquer, A. Galmes, A. Obrador, M. Parera, and J. Bargay In hereditary haemochromatosis, red cell apheresis removes excess iron twice as fast as manual whole blood phlebototmy J Clin Apheresis 17 2 2002 88 92
45. O. Squarcia, S. Fais, M. Boirivant, M.C. DiPaolo, A. Marcheggiano, and C. Iannoni Phenotypes and spontaneous immunoglobulin production in mononuclear cells suspensions isolated from colonic biopsies of patients with mild active and quiescent ulcerative colitis Gastroenterol Clin Biol 15 3 1991 194 198
46. K. Mitsuyama, A. Toyonaga, E. Sasaki, K. Watanabe, H. Tateishi, and T. Nishiyama Il-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease Clin Exp Immunol 96 3 1994 432 436
47. Y. Tsukada, T. Nakamura, M. Iimura, B.E. Iizuka, and N. Hayashi Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis Am J Gastroenterol 97 11 2002 2820 2828
48. B.J. Rembacken, H.E. Newbould, S.J. Richards, S.A. Misbah, M.E. Dixon, and D.M. Chalmers Granulocyte apheresis in inflammatory bowel disease: possible mechanism of effect Ther Apher 2 2 1998 93 96
49. Y. Ikeda, S.M. Akbar, H. Matsui, and M. Onji Characterization of antigen presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis Eur J Gastroenterlol Hepatol 13 7 2001 841 850
50. Y. Ikeda, S.M. Akbar, H. Matsui, and M. Onji Antigen presenting dendritic cells in ulcerative colitis J Gastroenterol 37 Suppl 14 2002 53 55
51. Y. Ikeda, S.M. Akbar, H. Matsui, and M. Onji Depletion and decreased function of antigen-presenting dendritic cells caused by lymphocytapheresis in ulcerative colitis Dis Colon Rectum 46 4 2003 521 528
52. T. Ayabe, T. Ashida, and Y. Kohgo Centrifugal leukocytapheresis for ulcerative colitis Ther Apher 2 2 1998 125 128
53. K. Kondo, T. Shinoda, H. Yoshimoto, M. Takazoe, and T. Hamada Effective maintenance leukocytapheresis for patients with steroid dependent or resistant ulcerative colitis Ther Apher 5 6 2001 462 465
54. T. Shimoyama, K. Sawada, N. Hiwatashi, T. Sawada, K. Matsueda, and A. Manakata Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study J Clin Apheresis 16 1 2001 1 9
55. Y. Kohgo, H. Hibi, T. Chiba, T. Shimoyama, T. Muto, and K. Yamamura Leukocyte apheresis using a centrifugal cell separator in refractory ulcerative colitis: a multicenter open label trial Ther Apher 6 4 2002 255 260
56. Y. Kohgo, T. Ashida, A. Maemoto, and T. Ayabe Leukocytapheresis for treatment of IBD J Gastroenterol 38 Suppl 15 2003 51 54
57. T. Nakamura, Y. Suzuki, and H. Koide Granulocyte and monocyte adsorption apheresis in a patient with antiglomerular basement membrane glomerulonephritis and active ulcerative colitis Am J Med Sci 325 5 2003 296 298
58. K. Sawada, T. Muto, T. Shimoyama, M. Satomi, T. Sawada, and I. Nagawa Multicenter randomized controlled trial from the treatment of ulcerative colitis with a leukocytapheresis column Curr Pharm Des 9 4 2003 307 321
59. T. Matsui, T. Nishimura, H. Matake, T. Ohta, T. Sakurai, and T. Yao Granulocytapheresis for Crohn's disease: a report of seven refractory patients Am J Gastroenterol 98 2 2003 511 512
60. J.P. Hester, M.C. Dignani, N.J. Anaissie, H.M. Kantarjian, S. O'Brien, and E.J. Freireich Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infections J Clin Apher 10 1995 188 193
61. T.H. Price Granulocyte transfusion in the G-CSF era Int J Hematol 76 Suppl 2 2002 77 80
62. J. Bux, U. Cassens, T. Dielschneider, M. Duchscherer, E. Edel, and H. Eichler Tolerance of granulocyte donors towards granulocyte colony-stimulating factor stimulation and of patients towards granulocyte transfusions: results of a multicentre study Vox Sang 85 4 2003 322 325
63. S. Bashir, and R. Cardigan Granulocyte concentrates: how can we assess their quality? Transfus Med 13 5 2003 245 258
64. M.A. Briones, C.D. Josephson, and C.D. Hillyer Granulocyte transfusion revisited Curr Hematol Rep 2 6 2003 522 527
65. H. Borberg Zelluläre Substitution R. Gross C.G. Schmidt Klinische Onkologie 1985 G. Thieme New York 20.20 20.29
66. S. Cesaro, P. Chinello, G. DeSilvestro, P. Marson, G. Picco, and S. Varotto Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases Support Care Cancer 11 2 2003 101 106
67. S. Rutella, L. Pierelli, S. Sica, R. Serafini, P. Chiusolo, and U. Paladini Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors Cytotherapy 5 1 2003 19 30
68. L. Grigull, A. Schrauder, A. Schmitt-Thomsen, K. Sykora, and K. Welte Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection Infection 30 2003 267 271
69. G. Illerhaus, K. Wirth, A. Dwenger, C.F. Waller, A. Garbe, and V. Brass Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions Ann Hematol 81 5 2002 273 281
70. Y. Tsukada, H. Nagayama, T. Mori, T. Shimizu, N. Sato, and N. Takayama Granulocyte transfusion as a treatment for enterococcal meningoencephalitis after allogeneic bone marrow transplantation from an unrelated donor Bone Marrow Transplant 31 1 2003 69 72
71. R. Vij, J.F. DiPersio, P. Venkatraman, K. Trinkaus, L.T. Goodnough, and R.A. Brown Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation Blood 101 5 2003 2067 2069
72. W.G. Nichols, T. Price, and M. Boeckh Cytomegalovirus infections in cancer patients receiving granulocyte transfusions Blood 99 9 2002 3483 3484
73. M. Cella, F. Sallusto, and A. Lanzavecchia Origin, maturation and antigen presenting function of dendritic cells Curr Opin Immunol 9 1 1997 10 16
74. J.C. Gluckman, B. Canque, F. Chapuis, and M. Rosenzwajg In vitro generation of human dendritic cells and cell therapy Cytokines Cell Mol Ther 3 3 1997 187 196
75. S. Grabbe, E. Kampgen, and G. Schuler Dendritic cells: multi-lineal and multi-functional Immunol Today 21 9 2000 431 433
76. C. Ardavin, G. Martinez delHoyo, P. Martin, F. Anjuerre, C.F. Arias, and S. Ruiz Origin and differentiation of dendritic cells Trends Immunol 22 12 2001 691 700
77. G. Meierhoff, S.W. Krause, and R. Andreesen Comparative analysis of dendritic cells derived from blood monocates or CD 34+ haematopoietic progenitor cells Immunobiology 198 5 1998 501 513
78. V. Cerundolo, I.F. Hermans, and M. Salio Dendritic cells: A journey from laboratory to clinic Nat Immunol 5 1 2004 7 10
79. M.S. Labeur, B. Roters, B. Pers, A. Mehling, T.A. Luger, and T. Schwarz Generation of tumour immunity by bone marrow derived dendritic cells correlates with dendritic cell maturation J Immunol 162 1 1999 168 175
80. M. Gunzer, and S. Grabbe Dendritic cells in cancer immunotherapy Crit Rev Immunol 21 1-3 2001 133 145
81. M. Gunzer, S. Janich, G. Varga, and S. Grabbe Dendritic cells and tumor immunity Semin Immunol 13 5 2001 291 302
82. A. Nolte, C. Scheffold, J. Slotty, C. Huenefeld, J.L. Schultze, and S. Grabbe Generation of melanoma-specific cytotoxic T lymphocytes for allogeneic immunotherapy J Immunother 26 3 2003 257 269
83. Sorg R, Brefort Th, Fischer J, Ackermann R, Wernet P. Clinical scale generation of dendritic cells in a closed system. In: 7th International symposium on dendritic cells, Bamberg, Germany, 19-24 September 2002. p. 186.
84. Chui SY, Clay TM, Hobeika AC, Venturi CB, Osada T, Khan S, et al. Dendritic cell vaccination following high dose chemotherapy with autologous stem cell support for breast cancer: long term follow up ASCO, 2003. Abstract no. 682.
85. C. Craddock Haemopoietic stem-cell transplantation: recent progress and future Lancet Oncol 1 2000 227 234
86. N. Saba, R. Abraham, and A. Keating Overview of autologous stem cell transplantation Crit Rev Oncol Hematol 36 1 2000 27 48
87. A. Urbano-Ispizua, N. Schmitz, T. deWitte, F. Frassoni, G. Rosti, and H. Schretzenmeier Allogeneic and autologous transplantation for haematological diseases, solid tumors, and immune disorders: definitions and current practice in Europe Bone Marrow Transplant 29 8 2002 639 646
88. J. Jansen, J.M. Thompson, M.J. Dugan, P. Nolan, M.C. Wiemann, and R. Birhiray Peripheral blood progenitor cell transplantation Ther Apher 6 1 2002 5 14
89. W.I. Bensinger, and R. Storb Allogeneic peripheral blood stem cell transplantation Rev Clin Exp Haematol 5 2 2001 67 86
90. N.C. Gorin Autologous stem cell transplantation for adult acute leukaemia Curr Opin Oncol 14 2 2002 152 159
91. M. Körbling, and Z. Estrov Adult stem cells for tissue repair-a new therapeutic concept N Engl J Med 349 2003 570 582
92. G. Ferrari, G. Cusella-DeAngelis, M. Coletta, E. Paolucci, A. Stornaiuolo, and G. Cossu Muscle regeneration by bone marrow derived mogenic progenitors Science 279 5356 1998 1528 1533
93. G. Ferrari, and F. Mavilio Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy? Neuromusc Disord 12 Suppl 1 2002 S7 S10
94. B. Johnstone, T.M. Hering, A.L. Caplan, V.C. Goldberg, and J.U. Yoo In vitro chondrogenesis of bone marrow derived mesenchymal progenitor cells Exp Cell Res 238 1998 265 272
95. E. Lagasse, H. Connors, M. Al-Dhalimy, M. Reitsma, M. Dohse, and G. Osborne Purified hematopoietic stem cells can differentiate into hepatocytes in vivo Nat Med 6 11 2000 1212 1213
96. M. Körbling, R.L. Katz, A. Khanna, A.C. Ruifroc, G. Rondon, and M. Albitar Hepatocytes and epithelial cells of donor origin in recipients of peripheral blood stem cells N Engl J Med 346 2002 738 746
97. D. Orlic, J. Kaystura, S. Chimenti, F. Limana, I. Jakoniuk, and F. Quani Mobilized bone marrow cells repair the infarcted heart, improving function and survival Proc Natl Acad Sci 98 2001 10344
98. D. Orlic, J. Kaystura, S. Chimenti, I. Jakoniuk, S.M. Anderson, and L. Baosheng Bone marrow cells regenerate infarcted myocardium Nature 410 2001 701 705
99. J.T. Vilquin, J.P. Marolleau, A. Hagege, P. Menasche, M. Fiszman, and K. Schwartz Cell transplantation for post ischaemic-heart failure Arch Mal Coeur Vaiss 95 12 2002 1219 1225
100. B.E. Strauer, M. Brehm, T. Zeus, M. Kostering, A. Hernadez, and R.V. Sorg Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 106 2002 1913 1918
101. T. Imasawa, Y. Utunomiya, T. Kawamura, Y. Zhong, R. Nagasawa, and M. Okabe The potential of bone marrow derived cells to differentiate to glomerular mesangial cells J Am Soc Nephrol 12 7 2001 1401 1409
102. T. Ito, A. Susuki, E. Imai, M. Okabe, and M. Hori Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling J Am Soc Nephrol 12 2001 2625 2635
103. S. Kale, A. Karihaloo, P.R. Clark, M. Kashgarian, D.S. Krause, and L.G. Cantley Bone marrow stem cells contribute to the repair of the ischemically injured renal tube J Clin Invest 112 2003 42 49
104. J. Chen, Y. Li, L. Wang, Z. Zhang, D. Lu, and M. Lu Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats Stroke 32 2001 1005 1011
105. J. Priller, D.A. Persons, F.F. Klett, G. Kempermann, G.W. Kreutzberg, and U. Dirnagl Neogenesis of cerebellar Purkinje neurons from gene-marked bone marrow cells in vivo J Cell Biol 155 2001 733 738
106. D.N. Kotton, B.Y. Ma, W.V. Cardoso, E.A. Sanderson, R.S. Summer, and M.C. Williams Bone marrow derived cells as progenitors of lung alveolar epithelium Development 128 2002 5181 5188
107. M. Tomita, Y. Adachi, H. Yamada, K. Takahashi, K. Kiuchi, and H. Oyaizu Bone marrow derived stem cells can differentiate into retinal cells in injured rat retina Stem Cells 20 2002 279 283
108. A. Kicic, W.Y. Shen, A.S. Wilson, I.J. Constable, T. Robertson, and P.E. Rakoczy Differentiation of marrow stroma cells into photoreceptors in the rat eye J Neurosci 23 2003 7742 7749
109. S. Hacein-Bay-Abina, C. von Kalle, M. Schmidt, F. LeDeist, N. Wulffraat, and E. McIntyre A serious adverse event after successful gene therapy for x-linked severe combined immunodeficiency by ex vivo gene therapy N Engl J Med 348 3 2003 255 256
110. E. Check Gene therapy: shining hopes dented-but not dashed Nature 420 6917 2002 735
111. H. Borberg Zur Immuntherapie von Tumoren: Die adoptive Immunisierung als Mittel der Wachs tumshemmung und Rückbildung transplantierter Fibrosarkome der Maus Verhdl Deutsch Ges Inn Med 76 1970 113 116
112. H. Borberg, H.F. Oettgen, K. Choudry, and E.J. Beattie Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors Int J Cancer 10 1972 539 547
113. D. Avigan Dendritic cells: development, function, and potential use for cancer Blood Rev 13 1 1999 51 64
114. C. Esche, M.R. Shurin, and M.T. Lotze The use of dendritic cells for cancer vaccination Curr Opin Mol Ther 1 1 1999 72 81
115. M.S. Labeur, B. Roters, B. Pers, A. Mehling, T.A. Luger, and T. Schwarz Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage J Immunol 162 1 1999 168 175
116. M.V. Dhodapkar, and N. Bhardwaj Active immunization of humans with dendritic cells J Clin Immunol 20 3 2000 167 174
117. M. Nonn, M. Schinz, K. Zumbach, M. Pawlita, A. Schneider, and M. Durst Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation of recombinant protein-pulsed dendritic cells induces specific T cell to HPV16E7 or HPV18E/7 J Cancer Res Clin Oncol 129 9 2003 511 520
118. M. Ferrara, M. Nonn, P. Sehr, C. Schreckenberger, M. Pawlita, and M. Durst Dendritic cell based-tumor vaccine for cervival cancer II: results of a clinical pilot study in 15 individual patients J Cancer Res Clin Oncol 129 9 2003 521 530
119. Chui SY, Clay TM, Hobeika AC, Venturi CB, Osada T, Khan S, et al. Dendritic cell vaccination following high dose chemotherapy with autologous stem cell support for breast cancer: long term follow up. In: Proceedings, ASCO 2003. Abstract no. 682.
120. R. Weber, M. Azemar, B. Hildenbrand, and C. Unger Dendritic cell based immunotherapy in patients with hormone resistant prostata carcinoma in combination with interferon gamma Onkologie 26 Suppl 1 2003 22
121. M. Lindauer, T. Stanislawski, A. Haussler, E. Antunes, A. Cellary, and C. Huber The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes J Mol Med 76 1 1998 32 47
122. L.A. Sherman, M. Theobald, D. Morgand, J. Hernandez, I. Bacik, and J. Yewdell Strategies for tumor elimination by cytotoxic T lymphocytes Crit Rev Immunol 18 1-2 1998 47 54
123. A.K. Thomas, J. Finke, and H. Veelken Adoptive T cell transfer Onkologie 26 Suppl 1 2003 20
124. N. Kröger, R. Schwerdtfeger, M. Kiehl, H.G. Sayer, H. Renges, and T. Zabelina Autologous stem cell transplantation followed by a dose reduced allograft induces high complete remission rate in multiple myeloma Blood 100 3 2002 755 760
125. M.H. Gilleece, and F. Dazzi Donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukaemia Leuk Lymphoma 44 1 2003 23 28
126. B.R. Dey, S. McAfee, C. Colby, R. Sackstein, S. Saidman, and N. Tarbell Impact of prophylactic donor leukocyte infusion on mixed chimerism, graft versus host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation Biol Blood Marrow Transplant 9 5 2003 320 329
127. J. Schetelig, C. Thiede, M. Bornhauser, R. Schwerdtfeger, M. Kiel, and J. Beyer Evidence of graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the cooperative German Transplant Study Group J Clin Oncol 21 14 2003 2747 2753
128. J. Hester A clinical role for peripheral blood lymphocyte infusions and perspectives on collection Ther Apher Dial 7 3 2003 305 311
129. S. Slavin Graft-versus-host disease, the graft-versus-leukemia effect and mixed chimerism follo wing nonmyeloablative stem cell transplantation Int J Hematol 78 3 2003 195 207
130. Y.H. Ji, L. Weiss, M. Zeira, A. Abdul-Hai, S. Reich, and L. Schuger Allogeneic cell-mediated immunotherapy of leukemia with immune donor lymphocytes to upregulate antitumor effects and downregulate antihost responses Bone Marrow Transplant 32 5 2003 495 504
131. S. Humblet-Baron, F. Baron, Y. Beguin, A. Chachati, J. Bury, and E. Morelon Donor lymphocyte infusion for late relapse followed by kidney transplantation for end- stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia Transplantation 76 10 2003 1531 1532
132. J.W. Nortier, J.H. Falkenburg, and R. Willemze Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors Exp Hematol 10 2003 865 872
133. M. Das, T.K. Saikia, S.H. Advani, P.M. Parikh, and S. Tawde Use of a reduced-intensity conditioning regimen for allogeneic transplantation in patients with chronic myeloid leukemia Bone Marrow Transplant 32 2 2003 125 129
134. S. Slavin, S. Morecki, L. Weiss, and R. Or Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man Crit Rev Oncol Hematol 46 2 2003 139 163
135. H. Bertz, K. Potthoff, and J. Finke Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia J Clin Oncol 21 8 2003 1480 1484
136. A.M. Raiola, M.T. Van Lint, M. Valbonesi, T. Lamparelli, F. Gualandi, and D. Occhini Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions Bone Marrow Transplant 31 8 2003 687 693
137. P. Lewalle, A. Triffet, A. Delforge, P. Crombez, D. Selleslag, and H. DeMuynck Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study Bone Marrow Transplant 31 1 2003 39 44
138. C.K. Lee, M. deMagalhaes-Silverman, R.J. Hohl, M. Hayashi, and J. Buatti Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft Bone Marrow Transplant 31 2 2003 121 128
139. R. Bellucci, C.J. Wu, S. Chiaretti, E. Weller, F.E. Davies, and E.P. Alyea Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens Blood 103 2 2004 656 663
140. W.A. Bethge, U. Hegenbart, M.J. Stuart, B.E. Storer, M.B. Maris, and M.E. Flowers Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hemato poietic cell transplantation following nonmyeloablative conditioning Blood 103 3 2004 790 795 1
141. F.P. Gasparro, R. Dall'Amico, D. Goldminz, E. Simmons, and D. Weingold Molecular aspects of extracorporeal photochemotherapy Yale J Biol Med 62 6 1989 579 593
142. R.L. Edelson Photopheresis: a clinically relevant immunobiologic response modifier Ann NY Acad Sci 636 1991 154 164
143. R.L. Edelson Cutanous T-cell lymphoma. A model for selective immunotherapy Cancer J Sci Am 4 2 1998 62 71
144. P.W. Heald, and R.L. Edelson Photopheresis for T-cell mediated diseases Adv Dermatol 3 1988 25 40
145. P.W. Heald, H.Y. Kim, M. Perez, R.L. Edelson, and C.L. Berger T-cell responses in photoimmune therapy J Clin Apher 10 3 1995 144 149
146. F. Heshmati Mechanisms of action of extracorporeal photochemotherapy Transfus Apher Sci 29 1 2003 61 70
147. M. Girardi, J. Schechner, E. Glusac, C. Berger, and R. Edelson Transimmunization and the evolution of extracorporeal photochemotherapy Transfus Apher Sci 26 3 2002 181 190
148. A.H. Rook, and J.T. Wolfe Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection J Clin Apheresis 9 1 1994 28 30
149. J.T. Wolfe, S.R. Lessin, A.H. Singh, and A.H. Rook Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection Artif Organs 18 12 1994 888 897
150. R. Edelson, C. Berger, F. Gasparro, B. Jegasothy, P. Heald, and B. Wintroub Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy. Preliminary results N Engl J Med 316 1987 297 303
151. R.L. Edelson Sezary syndrome, cutaneous T-cell lymphoma and extracorporeal photopheresis Arch Dermatol 135 5 1999 600 601
152. A.H. Rook, S.L. Gottlieb, J.T. Wolfe, B.R. Vowels, S.S. Sood, and Z. Niu Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis Clin Exp Immunol 107 Suppl 1 1997 16 20
153. K.R. Suchin, A.J. Cucchiara, S.L. Gottleib, J.T. Wolfe, B.J. DeNardo, and W.H. Macey Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution Arch Dermatol 138 8 2002 1054 1060
154. S.L. Gottlieb, J.T. Wolfe, F.E. Fox, B.J. DeNardo, W.H. Macey, and P.G. Bromley Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution J Am Acad Dermatol 35 6 1996 946 957
155. S. Ingen-Housz-Oro, A. Bussel, B. Flageul, L. Dubertret, L. Michel, and G. Gachelin Follow-up of the T-cell clonality in Sezary patients treated by extracorporeal photopheresis using a new assay: the immunoscope technique Transfus Apher Sci 28 2003 35 42
156. R. Dall'Amico, F. Zulian, G. Montini, B. Andreetta, L. Murer, and F. Rosetti Application of extracorporeal photochemotherapy in "non- oncological" diseases Int J Artif Organs 16 Suppl 5 1993 168 172
157. M. Owsianowski, H. Gollnick, W. Siegert, R. Schwerdtfeger, and C.E. Orfanos Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis Bone M Transpl 14 5 1994 845 848
158. F. Rosseti, R. Dall'Amico, G. Crovetti, C. Messina, G. Montini, and G. Dini Extracorporeal photochemotherapy for the treatment of graft-versus-host disease Bone Marrow Transpl 18 Suppl 2 1996 175 181
159. F. Heshmati, R. Tavakoli, A. Michel, A. Achkar, R. Guillemain, and J.P. Couctil Extracorporeal photochemotherapy: a treatment for organ graft rejection Ther Apher 1 2 1997 121 125
160. F. Heshmati, and G. Andreu Extracorporeal photochemotherapy: a historical perspective Transfus Apher Sci 28 1 2003 25 34
161. H.A.T. Greinix, B. Volc-Platzer, P. Kalhs, G. Fischer, A. Rosenmayr, and F. Keil Extracorporeal photochemotherapy in the treatment of severe steroid-refractory graft-versus-host disease: a pilot study Blood 96 7 2000 2426 2431
162. J.T. Wolfe, J.E. Tomaszewski, R.A. Grossman, S.L. Gottlieb, A. Naji, and K.L. Brayman Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature J Clin Apheresis 11 1 1996 36 41
163. M.R. Constano-Nordin, E.A. Hubbel, E.J. O'Sullivan, M.R. Johnson, G.H. Mullen, and A.L. Heronx Successfull treatment of heart transplant rejection with photopheresis Transplantation 53 1992 808 815
164. B.M. Meiser, F. Kur, H. Reichenspurner, F. Wagner, K.S. Boogs, and S. Vielhauer Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation Transplantation 57 4 1994 563 568
165. M.L. Barr, B.M. Meiser, H.J. Eisen, R.F. Roberts, U. Livi, and R. Dall'Amico Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis transplantation study group N Engl J Med 339 24 1998 1744 1751
166. G. Andreu, A. Achkar, J.P. Couetil, R. Guillemain, F. Heshmati, and C. Amrein Extracorporeal photochemotherapy treatment for acute lung rejection episode J Heart Lung Transplant 14 4 1995 793 796
167. G. Guariso, R. D'Inca, G.C. Sturniolo, L. Zancan, and R. Dall'Amico Photopheresis treatment in severe Crohn's disease J Pediatr Gastroenterol Nutr 37 4 2003 517 520
168. L. Laroche, R.L. Edelson, M. Perez, and C.L. Berger Antigen specific tolerance induced by autoimmunization with photoinactiveted syngeneic effector cells Ann NY Acad Sci 636 1991 113 123
169. G. Andreu, C. Boccacio, J.P. Leguen, and M. Oleggini Ultraviolet light induced immunomodulation: a possible new tool in organ transplantation Ann Med Intern (Paris) 143 Suppl 1 1992 52 56
170. A.H. Rook, B.V. Jegasothy, P. Heald, G.T. Nahass, C. Ditre, and W.K. Witmer Extracorporeal photochemotherapy for drug resistant pemphigus vulgaris Ann Intern Med 112 4 1990 303 305
171. R.M. Knobler, W. Graninger, A. Lindmaier, F. Trautinger, and J.S. Smolen Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A Pilot study Arthritis Rheum 35 3 1992 319 324
172. R.M. Knobler Extracorporeal photochemotherapy for the treatment of lupus erythematosus: preliminary observations Springer Semin Immunopathol 16 2-3 1994 323 325
173. S.E. Malawista, D. Trock, and R.L. Edelson Photopheresis for rheumatoid arthritis Ann NY Acad Sci 636 1991 217 226
174. S.E. Malawista, D. Trock, and R.L. Edelson Treatment of rheumatoid arthritis by extracorporeal photochemotherapy. A pilot study Arthritis Rheum 34 6 1991 646 654
175. P. Hilliquin, G. Andreu, F. Heshmati, and C.J. Menkes Treatment of refractory rheumathoid polyarthritis by extracorporeal photochemotherapy Rev Rhum Ed Fr 60 2 1993 125 130
176. P. Hillequin, and C.J. Menkes Photochemotherapy for refractory rheumatoid arthritis J Rheumatol 23 2 1996 406 407
177. W. Macheiner, C. Jantschitsch, W. Graininger, K. Paloczy, G. Balint, and M. Marschalko Sezary syndrome and seronegative polyarthritis: treatment with extracorporeal photochemotherapy J Am Acad Dermatol 48 2 2003 220 226
178. T. Agishi, M. Chikamori, T. Suzuki, K. Ota, H. Amemiya, and N. Sugino Effect of double filtration plasmapheresis on peripheral circulation T. Oda Therapeutic Plasmapheresis I 1981 FK Schattauer Stuutgart 119 124
179. H. Borberg, R. Brunner, M. Tauchert, and R. Widder The current state of extracorporeal haemorheotherapy: from haemodilution via cascade filtration to rheohaemapheresis Transf Apher Sci 24 2001 57 64
180. Th. Schreiner, S. Rink, R. Brunner, and H. Borberg First experience with a ready-for-use rheohaemapheresis system Transf Apher Sci 24 2001 125 128
181. P. Schuff-Werner, E. Schütz, W.C. Seyde, T. Eisenhauer, G. Janning, and V.W. Armstrong Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin induced extracorporeal LDL precipitation Eur J Clin Invest 19 1988 30 37
182. R.A. Widder, R. Brunner, B. Engels, H. Borberg, and K. Oette Changes of haemorheological and biochemical parameters after plasma perfusion using a tryptophane-polyvinylalcohol adsorber leading to clinical improvement in patients suffering from maculopathy Blood Purificat 16 1998 15 21
183. C. Otto, W.O. Richter, and P. Schwandt Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: evaluation by selective depletion of low-density lipoproteins or fibrinogen Metabolism 49 6 2000 810 813
184. W.O. Richter, P. Jahn, N. Jung, E. Nielebock, and H. Tachezy Fibrinogen adsorption in the diabetic foot syndrome and peripheral arterial occlusive disease: first clinical experience Ther Apher 5 5 2001 335 339
185. R. Brunner, R.A. Widder, P. Walter, C.H. Lüke, K.U. Bartz-Schmidt, and K. Heimann Influence of membrane differential filtration on the natural course of age-related macular degeneration. A randomised trial Retina 20 5 2000 483 491
186. J.S. Pulido Multicenter prospective, randomised, double-masked, placebo-controlled study of rheopheresis to treat nonexudative age-related macular degeneration: interim analysis Trans Am Ophthalmol Soc 100 2002 85 106
187. Widder RA, Farvili E, Reis RGJ, Lüke C, Walter P, Kirchhof B, et al. The Treatment of age-related macular degeneration (ARMD) with extracorporeal treatment procedures. A follow-up of four years. In: Annual meeting of the Association for Research in Vision and Ophthalmology (ARVO), 2002, A 2906.
188. M. Tauchert, A. Sonntag, B. Weidmann, A. Gaczkowski, R. Brunner, and H. Borberg Extracorporeal hemorheotherapy of refractory angina pectoris Jpn J Apheresis 16 1 1997 35 37
189. M. Suckfüll, J. Thiery, K. Schorn, E. Kastenbauer, and D. Seidel Clinical utility of LDL-elimination in the treatment of sudden hearing loss: a prospective randomised study Acta Otolaryngol 119 7 1999 763 766
190. M. Suckfüll, and Hearing Loss Study Group Fibrinogen and LDL-apheresis in treatment of sudden hearing loss: a randomized multicentre trial Lancet 360 9348 2002 1811 1817
191. C. Lüke, R.A. Widder, F. Soudavar, P. Walter, R. Brunner, and H. Borberg Improvement of macualar function in diabetic retinopathy J Clin Apher 16 2001 23 28
192. H. Borberg, R. Brunner, M. Tauchert, and R. Widder The current state of extracorporeal haemorheotherapy: From haemodilution via cascade filtration to rheohaemapheresis Transfus Apher Sci 24 2001 57 64
193. H. Borberg, R. Brunner, A. Gaczkowski, M. Michel, T. Schreiner, and M. Tauchert The role of rheology in hemapheresis Ther Apher 5 2 2001 128 133
194. R. Brunner, R.A. Widder, R.A. Fischer, P. Walter, K.U. Bartz-Schmitz, and K. Heimann Clinical efficacy of haemorheological treatment using plasma exchange, selective adsorption and cascade filtration in maculopathy, retinal vein occlusion and uveal effusion syndrome Transfus Sci 17 1997 493 498
195. M. Takamori, and Y. Ide Specific removal of anti-acetylcholine receptor antibodies in patients with myasthenia gravis Transfus Sci 17 3 1996 445 453
196. M. Takamori, and T. Maruta Immunoadsorption in myasthenia gravis based on specific ligands mimicking the immunogenic sites of the acetylcholine receptor Ther Apher 5 5 2001 340 350
197. G. Wallukat, J. Muller, and R. Hetzer Specific removal of beta 1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy N Engl J Med 347 22 2002 1806
198. G. Wallukat, P. Reinke, W.V. Dorffel, H.P. Luther, K. Bestvater, and S.B. Felix Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption Int J Cardiol 54 2 1996 191 195
199. W.V. Dorffel, S.B. Felix, G. Wallukat, S. Brehme, K. Bestvater, and T. Hofmann Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy Circulation 95 8 1997 1994 1997
200. W.V. Dorffel, G. Wallukat, G. Baumann, and S.B. Felix Immunoadsorption in dilated cardiomyopathy Ther Apher 4 3 2000 235 238
201. J. Müller, G. Wallukat, M. Dandel, H. Bieda, K. Brandes, and S. Spiegelsberger Immunoglobulin adsorption in patients with idiopathic dilatative cardiomyopathy Circulation 101 4 2000 385 391
202. T. Christ, D. Dobrev, G. Wallukat, S. Schuler, and U. Ravens Acute hemodynamic effects during immunoadsorption in patients with dilated cardiomyopathy positive for beta 1-adrenoreceptor autoantibodies Methods Find Exp Clin Pharmacol 23 3 2001 141 144
203. S.B. Felix, A. Staudt, M. Landsberger, Y. Grosse, V. Stangl, and T. Spielhagen Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption J Am Coll Cardiol 39 4 2002 646 652
204. P.P. Liu, and J.W. Mason Advances in the understanding of myocarditis Circulation 104 2001 1076 1094
205. M.A. Pascual, M. Crespo, and N. Tolkoff-Rubin Progress in understanding humoral rejection in kidney transplantation: implication for patient management Nefrologia 21 4 2001 327 331
206. C.J. Sonnenday, L.E. Ratner, A.A. Zachary, J.F. Burdick, M.D. Samaniego, and E. Krau Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match Transplant Proc 34 5 2002 1614 1616
207. H. Shimmura, K. Tanabe, N. Ishikawa, T. Tokumoto, S. Fuchinoue, and K. Takahashi Removal of anti-A/B antibodies with plasmapheresis in ABO-incompatible kidney transplantation Ther Apher 4 5 2000 395 398
208. R.A. Montgomery, A.A. Zachary, L.C. Racusen, M.S. Leffell, K.E. King, and J. Burdick Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients Transplantation 70 6 2000 887 895
209. A.A. Zachary, R.A. Montgomery, L.E. Ratner, M. Samaniego-Picota, M. Haas, and D. Kopchaliiska Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients Transplantation 76 10 2003 1519 1525
210. A. Kornberg, O. Dietz, H. Mau, J. Scheele, and C. Hammer Impact of Ig-Therasorb immunoapheresis on stability of xenogeneic ex vivo porcine liver perfusion-value of aminotransferases and flow rates for the assessment of metabolic graft viability Clin Chem Lab Med 38 11 2000 1187 1190
211. J.G. Gaca, W. Lee, O. Aksoy, S.J. Braedehoeft, G.V. Gonzalez-Stawinski, and W. Parker Evidence for polyreactive xenoreactive antibodies in the repertoire of human anti-swine antibodies: the 'next' humoral barrier to xenotransplantation? Transpl Immunol 9 1 2001 19 27
212. J.G. Gaca, W. Lee, O. Aksoy, S.J. Braesdehöft, G.V. Gonzalez-Stawinski, and W. Parker Evidence for polyreactive antibodies in the repertoire of human anti-swine antibodies: the 'next' humoral barrier to xenotransplantation? Transpl Immunol 9 1 2001 19 27
213. M. Javeed, T.P. Nifong, R.E. Domen, and W.B. Rybka Durable response to combination therapy including staphylococcal protein A immunoadsorption in life-threatening refractory autoimmune hemolysis Transfusion 42 9 2002 1217 1220
214. R. Miyazawa, A. Hikima, Y. Takano, H. Arakawa, T. Tomomasa, and A. Morikawa Plasmapheresis in fulminant acute disseminated encephalomyelitis Brain Dev 23 6 2001 424 426
215. E. Dittrich, S. Schmaldienst, M. Langer, M. Jansen, W.H. Hörl, and K. Derfler Immunoadsorption and plasma exchange in pregnancy Kidney Blood Press Res 25 4 2002 232 239
216. J.O. Piontek, H. Borberg, S. Sollberg, and T. Krieg Severe exacerbation of pemphigus vulgaris in pregnancy: successful treatment with plasma exchange Br J Dermatol 143 2000 455 456
217. Y. Matsuki, K. Suzuki, M. Kawakami, T. Ishizuka, Y. Kawaguchi, and T. Hidaka High avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns J Clin Apheresis 11 1996 30 35
218. K. Suzuki, Y. Matsuki, T. Hidaka, T. Ishizuka, M. Kawakami, and S. Takata Anti-DNA antibody kinetics following selective removal by adsorption using dextran sulfate cellulose columns in patients with systemic lupus erythematosus J Clin Apheresis 11 1996 16 22
219. M. Gaubitz, M. Seidel, S. Kummer, H. Schotte, A. Perniok, and W. Domschke Prospective randomized trial of two different immunadsorbers in severe systemic lupus erythematosus J Autoimm 11 1998 495 501
220. N. Braun, M. Junger, R. Klein, S. Gutenberger, M. Guagnin, and T. Risler Dextran sulfate plasma apheresis improves vascular changes in systemic lupus erythematosus Ther Apher 6 6 2002 471 477
221. D.T. Felson, M.P. LaValley, A.R. Baldassare, J.A. Block, J.R. Caldwell, and G.W. Cannon The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial Arthritis Rheum 42 10 1999 2153 2159
222. J.M. Millis, D.C. Cronin, R. Johnson, H. Conjeevaram, C. Conlin, and S. Trevino Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system, modifications and clinical impact Transplantation 74 12 2002 1735 1746
223. I.M. Sauer, and J.C. Gerlach Modular extracorporeal liver support Artif Organs 26 8 2002 703 706
224. A. Pascher, I.M. Sauer, C. Hammer, J.C. Gerlach, and P. Neuhaus Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience Xenotransplantation 9 5 2002 309 324
225. D. Samuel, P. Ichai, C. Feray, F. Saliba, D. Azoulay, and J.L. Arulnaden Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation Transplantation 73 2 2002 257 264
226. D. Samuel Bioartificial liver: present and future Transplantation 75 10 2003 1769 1770
227. J.C. Gerlach, K. Mutig, I.M. Sauer, P. Schrade, E. Efimova, and T. Mieder Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study Transplantation 76 5 2003 781 786
228. Y. Moussy Convective flow through a hollow fiber bioartificial liver Artif Organs 27 11 2003 1041 1049
229. J.F. Patzer II, R.C. Lopez, Y. Zhu, Z.F. Wang, G.V. Mazariegos, and J.J. Fung Bioartificial liver assist devices in support of patients with liver failure Hepatobiliary Pancreat Dis Int 1 1 2002 18 25
230. G. Ambrosino, and D.F. D'Amico Bioartificial liver support. Review and personal experience Minerva Chir 58 5 2003 649 656
231. P. Bruzzone, M. Rossiord, and P.B. Berloco Extracorporal liver perfusion as hepatic assist in acute liver failure: a review of world experience Xenotransplantation 10 5 2003 477
232. Y. Ueda, H. Iwata, H.J. Paek, I.K. Ko, Y. Shimooka, and N. Katsura Bioartificial liver with whole blood perfusion ASAIO J 49 4 2003 401 406
233. U. Kragh-Hansen, V.T. Chuang, and M. Otagiri Practical aspects of the ligand-binding and enzymatic properties of human serum albumin Biol Pharm Bull 25 6 2002 695 704
234. M. Hommann, L.B. Kasakow, J. Geoghegan, A. Kornberg, U. Schotte, and D. Fuchs Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child Pediatr Transplant 6 4 2002 340 343
235. M. Felldin, S. Friman, L. Backman, A. Siewert-Delle, B.A. Henriksson, and B. Larsson Treatment with the molecular adsorbent recirculating system in patients with acute liver failure Transplant Proc 35 2 2003 822 823
236. P. Faybik, H. Hetz, A. Baker, C. Bittermann, G. Berlakovich, and A. Werba Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning Liver Int 23 Suppl 3 2003 28 33
237. P. De Simone, M. Van Nuffelen, and V. Donckier Use of molecular adsorbent recirculating system for treatment of refractory pruritus Liver Transpl 9 9 2003 997 998
238. G. Schachschal, S. Morgera, S. Kupferling, H.H. Neumayer, H. Lochs, and H.H. Schmidt Emerging indications for MARS dialysis Liver 22 Suppl 2 2002 63 68
239. J. Stange, T.I. Hassanein, R. Mehta, S.R. Mitzner, and Rh. Bartlett The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers Artif Organs 26 2002 103 110
240. C. Natanson, C.J. Esposito, and S.M. Banks The sirens' songs of confirmatory sepsis trials: selection bias and sampling error Crit Care Med 26 12 1998 1927 1931
241. C. Brun-Buisson The epidemiology of the systemic inflammatory response Intensive Care Med 26 Suppl 1 2000 S64 S74
242. C. Brun-Buisson, F. Doyon, J. Carlet, P. Dellamonica, F. Gouin, and A. Lepoutre Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multi center prospective study in intensive care units. French ICU Group for Severe Sepsis JAMA 274 12 1995 968 974
243. M.H. Schoenberg, M. Weiss, and P. Radermacher Outcome of patients with sepsis and septic shock after ICU treatment Langenbecks Arch Surg 383 1 1998 44 48
244. E. Abraham The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051? Crit Care 6 4 2002 277 278
245. M.M. Levy, M.P. Fink, J.C. Marshall, E. Abraham, D. Angus, and D. Cook International sepsis definitions conference. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference Intensive Care Med 29 4 2003 530 538
246. H.S. Warren, A.F. Suffredini, P.Q. Eichacker, and R.S. Munford Risks and benefits of activated protein C treatment for severe sepsis N Engl J Med 347 13 2002 1027 1030
247. M. Murgo, H. Adamson, and M. Boyle The use of activated protein C (drotrecogin alfa (activated)) in the treatment of severe sepsis Aust Crit Care 16 4 2003 133 143
248. J. Barkun, and N.V. Christou CAGS Evidence Based Reviews in Surgery Group (Canadian Association of General Surgeons Evidence Based Reviews in Surgery). 8. Efficacy and safety of recombinant human activated protein C for severe sepsis Can J Surg 46 6 2003 468 470
249. E. Weil, and B. Vallet A definite role for treatment with activated protein C in sepsis? Yes J Thromb Haemost 1 12 2003 2466 2468
250. A.R. Girbes, and K.H. Polderman A definite role for treatment with activated protein C in sepsis? Standard use is premature J Thromb Haemost 1 12 2003 2469 2471
251. P.Q. Eichacker, and C. Natanson Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials Crit Care Med 31 1 Suppl 2003 S94 S96
252. P. Barton, A.C. Kalil, S. Nadel, B. Goldstein, R. Okhuysen-Cawley, and R.J. Brilli Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis Pediatrics 113 1 Pt 1 2004 7 17
253. J. Hellman, and H.S. Warren Antiendotoxin strategies Infect Dis Clin North Am 13 2 1999 371 386
254. R. Bellomo, I. Baldwin, and C. Ronco Extracorporeal blood purification therapy for sepsis and systemic inflammation: its biological rationale Contrib Nephrol 132 2001 367 374
255. R. Venkataraman, S. Subramanian, and J.A. Kellum Clinical review: extracorporeal blood purification in severe sepsis Crit Care 7 2 2003 139 145
256. C. Tetta, R. Bellomo, and C. Ronco Artificial organ treatment for multiple organ failure, acute renal failure, and sepsis: recent new trends Artif Organs 27 3 2003 202 213
257. C. Tetta, R. Bellomo, V. D'Intini, C. De Nitti, P. Inguaggiato, and A. Brendolan Do circulating cytokines really matter in sepsis? Kidney Int Suppl 84 2003 S69 S71
258. P. McMaster, and F. Shann The use of extracorporeal techniques to remove humoral factors in sepsis Pediatr Crit Care Med 4 1 2003 2 7
259. T. Soda, K. Ogura, M. Kondo, and M. Yagisawa Successful treatment with polymyxin B immobilized fiber of septic shock complicated by renal stone Int J Urol 5 2 1998 178 180
260. A.S. De Vriese, F.A. Colardyn, J.J. Philippe, R.C. Vanholder, J.H. De Sutter, and N.H. Lameire Cytokine removal during continuous hemofiltration in septic patients J Am Soc Nephrol 10 4 1999 846 853
261. P. Heering, S. Morgera, F.J. Schmitz, G. Schmitz, R. Willers, and H.P. Schultheiss Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration Intensive Care Med 23 3 1997 288 296
262. S. Ishihara, J.A. Ward, O. Tasaki, W.W. Brinkley, L.G. Seraile, and B.A. Pruitt Effects of long-term hemofiltration on circulating mediators and superoxide production during continuous endotoxin administration J Trauma 46 5 1999 894 899
263. C. Ronco, Z. Ricci, and R. Bellomo Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role for CVVH EDTNA ERCA J Suppl 2 2002 13 18
264. P. Toft, V. Brix-Christensen, J. Baech, J. Krog, H.S. Jorgensen, and E. Tonnesen Effect of hemodiafiltration and sepsis on chemotaxis of granulocytes and the release of IL-8 and IL-10 Acta Anaesthesiol Scand 46 2 2002 138 144
265. S. Morgera, D. Klonower, J. Rocktaschel, M. Haase, F. Priem, and S. Ziemer Neumayer HH. TNF-alpha elimination with high cut-off haemofilters: a feasible clinical modality for septic patients? Nephrol Dial Transplant 18 7 2003 1361 1369
266. W. Samtleben, S. Bengsch, K.S. Boos, and D. Seidel HELP apheresis in the treatment of sepsis Artif Organs 22 1 1998 43 46
267. A.T. Peter, S.R. Ash, J. Steczko, J.J. Turek, D.E. Blake, and D.J. Carr Push-pull sorbent-based pheresis treatment in an experimental canine endotoxemia model: preliminary report Int J Artif Organs 22 3 1999 177 188
268. S.R. Ash, J. Steczko, H. Levy, D.E. Blake, and D.J. Carr Treatment of systemic inflammatory response syndrome by push-pull powdered sorbent pheresis: a phase 1 clinica trial Ther Apher 5 6 2001 497 505
269. M. Kodama, K. Hanasawa, and T. Tani New therapeutic method against septic shock-removal of endotoxin using extra corporeal circulation Adv Exp Med Biol 256 1990 653 664
270. H. Aoki, M. Kodama, T. Tani, and K. Hanasawa Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber Am J Surg 167 4 1994 412 414
271. H. Weber, and D. Falkenhagen Extracorporeal removal of proinflammatory cytokines by specific absorption onto microspheres ASAIO J 42 5 1996 M908 M911
272. K.H. Staubach, J.A. Rosenfeldt, O. Veit, and H.P. Bruch Extracorporeal adsorption of endotoxin Ther Apher 1 1 1997 67 74
273. K.H. Staubach, M. Boehme, M. Zimmermann, and V. Otto A new endotoxin adsorption device in gram negative sepsis of immobilized albumin with the MATISSE adsorber Transfus Apher Sci 29 1 2003 93 98
274. B.L. Jaber, and B.J. Pereira Extracorporeal adsorbent-based strategies in sepsis Am J Kidney Dis 30 5 Suppl 4 1997 S44 S56
275. H. Shoji, T. Tani, K. Hanasawa, and M. Kodama Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application Ther Apher 2 1 1998 3 12
276. H. Shoji Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin) Therap Apher Dial 7 1 2003 108 114
277. M. Zimmermann, K. Busch, S. Kuhn, and M. Zeppezauer Endotoxin adsorbent based on immobilized human serum albumin Clin Chem Lab Med 37 3 1999 373 379
278. K. Hanasawa Extracorporeal treatment for septic patients: new adsorption technologies and their clinical application Ther Apher 6 4 2002 290 295
279. J. Schmidt, S. Mann, V.D. Mohr, R. Lampert, U. Firla, and H. Zirngibl Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis Intensive Care Med 26 5 2000 532 537
280. C. Ronco, A. Brendolan, V. d'Intini, Z. Ricci, M.L. Wratten, and R. Bellomo Coupled plasma filtration adsorption: rationale, technical development and early clinical experience Blood Purif 21 6 2003 409 416
281. M. Formica, C. Olivieri, S. Livigni, G. Cesano, A. Vallero, and M. Maio Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock Intensive Care Med 29 5 2003 703 708 Epub 2003 Mar 29
282. Handschel D. Konzeption und Initiierung einer Pilotstudie zur Untersuchung des Stellenwertes der Plasmaaustauschbehandlung als therapeutische Ergänzung des frühen septischen Schocks. Thesis, University of Cologne, 1999.
283. A. Hodgson, T. Ryan, J. Moriarty, G. Mellotte, C. Murphy, and O.P. Smith Plasma exchange as a source of protein C for acute onset of protein C pathway failure Br J Haematol 116 4 2002 905 908
284. R. Busund, V. Koukline, U. Utrobin, and E. Nedashkovsky Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial Intensive Care Med 28 10 2002 1434 1439
285. B.G. Stegmayr, R. Banga, and L. Bergren Plasma exchange as rescue therapy in multiple organ failure including acute renal failure Crit Care Med 31 2003 1730 1736
286. W. Stoffel, H. Borberg, and V. Greve Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia Lancet II 1981 1005 1007
287. G. Utermann, C. Haibach, M. Trommsdorff, S. Kochl, and A. Lingenhel Genetic architecture of the atherogenic lipoprotein(a) Ann NY Acad Sci 748 1995 301 312
288. G.M. Kostner, X. Wo, S. Frank, K. Kostner, R. Zimmermann, and E. Steyrer Metabolism of Lp(a): assembly and excretion Clin Genet 52 5 1997 347 354
289. M. Ogorelkova, H.G. Kraft, C. Ehnholm, and G. Utermann Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians Hum Mol Genet 10 8 2001 815 824
290. F. Kronenberg, A. Steinmetz, G.M. Kostner, and H. Dieplinger Lipoprotein(a) in health and disease Crit Rev Clin Lab Sci 33 6 1996 495 543
291. F. Kronenberg, M.F. Kronenberg, S. Kiechl, E. Trenkwalder, P. Santer, and F. Oberhollenzer Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study Circulation 100 11 1999 1154 1160
292. H.G. Kraft, A. Lingenhel, F.J. Raal, M. Hohenegger, and G. Utermann Lipoprotein(a) in homozygous familial hypercholesterolemia Arterioscler Thromb Vasc Biol 20 2 2000 522 528
293. K.M. Kostner, and G.M. Kostner The physiological role of lipoprotein (a Drug News Perspect 15 2 2002 69 77
294. K.M. Kostner, and G.M. Kostner Lipoprotein(a): still an enigma? Curr Opin Lipidol 13 4 2002 391 396 Review
295. M. Ignatescu, K. Kostner, G. Zorn, M. Kneussl, G. Maurer, and I.M. Lang Plasma Lp(a) levels are increased in patients with chronic thromboembolic pulmonary hypertension Thromb Haemost 80 2 1998 231 232
296. G. Christ, K. Kostner, M. Zehetgruber, B.R. Binder, D. Gulba, and K. Huber Plasmin activation system in restenosis: role in pathogenesis and clinical prediction? J Thromb Thrombolysis 7 3 1999 277 285
297. N.M. Caplice, C. Panetta, T.E. Peterson, L.S. Kleppe, C.S. Mueske, and G.M. Kostner Lipoprotein(a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis Blood 98 10 2001 2980 2987
298. C. Buechler, H. Ullrich, M. Ritter, M. Porsch-Oezcueruemez, K.J. Lackner, and S. Barlage Lipoprotein(a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes Blood 97 4 2001 981 986
299. H.J. Milionis, M.S. Elisaf, and D.P. Mikhailidis The effects of lipid-regulating therapy on haemostatic parameters Curr Pharm Des 9 29 2003 2425 2443
300. R. Marcucci, A.A. Liotta, A.P. Cellai, A. Rogolino, A.M. Gori, and B. Giusti Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism Am J Med 115 8 2003 601 605
301. G. Hoefler, F. Harnoncourt, E. Paschke, W. Mirtl, H. Pfeiffer, and G.M. Kostner Lipoprotein Lp(a). A rsik factor for myocardial infarction Arteriosclerosis 8 4 1988 398 401
302. M. Sandkamp, H. Funke, H. Schulte, E. Kohler, and G. Assmann Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age Clin Chem 36 1 1990 20 23
303. G.F. Watts, E.M. Kearney, N.A. Taub, and B.M. Slavin Lipoprotein(a) as an independent risk factor for myocardial infarction in patients with common hypercholesteroaemia J Clin Pathol 46 3 1993 267 270
304. B. Cantin, F. Gagnon, S. Moorjani, J.P. Despres, B. Lamarche, and P.J. Lupien Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study J Am Coll Cardiol 32 4 1998 1132 1134
305. G.H. Dahlen, and H. Stenlund Lp(a) lipoprotein is a major risk factor for cardiovascular disease: pathogenic mechanisms and clinical significance Clin Genet 562 5 1997 272 280
306. A.G. Bostom, L.A. Cupples, J.L. Jenner, J.M. Ordovas, L.J. Seman, and P.W. Wilson Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study JAMA 276 7 1996 544 548
307. A. Fujino, T. Watanabe, H. Kunii, N. Yamaguch, K. Yoshinari, and Y. Watanabe Lipoprotein(a) is a potential coronary risk factor Jpn Circ J 64 1 2000 51 56
308. P.N. Hopkins, S.C. Hunt, P.J. Sachreiner, J.H. Eckfeldt, I.B. Borecki, and C.R. Ellison Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study Atherosclerosis 141 2 1998 333 345
309. A. Lingenhel, H.G. Kraft, M. Kotze, A.V. Peeters, F. Kronenberg, and R. Kruse Concentrations of the atherogenic Lp(a) are elevated in FH Eur J Hum Genet 6 1 1998 50 60
310. A. Adlouni, M. el Messal, N. Ghalim, and R. Saile Apolipoproteins and lipoprotein particles in Moroccan patients with previous myocardial infarction Int J Clin Lab Res 27 4 1997 247 252
311. A. Von Eckardstein, H. Schulte, P. Cullen, and G. Assmann Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk J Am Coll Cardiol 37 2 2001 434 439
312. J.F. Price, A.J. Lee, A. Rumley, D.G. Lowe, and F.G. Fowkes Lipoprotein(a) and development of intermittent claudication and major cardiovascular events in men and Women: The Edinburgh Artery Study Atherosclerosis 157 1 2001 241 249
313. B. Cantin, J.P. Despres, B. Lamarche, S. Moorjani, P.J. Lupien, and P. Bogaty Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study) Am J Cardiol 89 6 2002 662 666
314. F. Kronenberg, P. Konig, U. Neyer, M. Auinger, A. Pribasnig, and U. Lang Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis J Am Soc Nephrol 6 1 1995 110 120
315. F. Kronenberg, G. Utermann, and H. Dieplinge Lipoprotein(a) in renal disease Am J Kidney Dis 27 1 1996 1 25
316. F. Kronenberg, E. Trenkwalder, A. Lingenhel, G. Friedrich, K. Lhotta, and M. Schober Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation J Lipid Res 38 9 1997 1755 1763
317. F. Kronenberg, E. Trenkwalder, W. Sturm, H. Kathrein, P. Konig, and U. Neyer LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients Clin Genet 52 5 1997 377 386
318. K.M. Kostner, M. Jansen, G. Maurer, and K. Derfler LDL-apheresis significantly reduces urinary apo(a) excretion Eur J Clin Invest 27 1 1997 93 95
319. K.M. Kostner, M. Clodi, G. Bodlaj, B. Watschinger, W. Horl, and K. Derfler Decreased urinary apolipoprotein(a) excretion in patients with impaired renal function Eur J Clin Invest 28 6 1998 447 452
320. L. Kerschdorfer, P. Konig, U. Neyer, C. Bosmuller, K. Lhotta, and M. Auinger Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up Atherosclerosis 144 2 1999 381 391
321. E. Cauza, J. Kletzmaier, G. Bodlaj, A. Dunky, W. Herrmann, and K. Kostner Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function Nephrol Dial Transplant 18 8 2003 1568 1572
322. L.A. Sechi, F. Kronenberg, S. De Carli, E. Falleti, L. Zingaro, and C. Catena Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension JAMA 277 21 1997 1689 1695
323. H. Shi, J. Fang, X. Yang, Z. Shen, and X. Zhu Lipoprotein(a) concentration and apolipoprotein(a) phenotype in subjects with type 2 diabetes mellitus Chin Med J 111 11 1998 1013 1017
324. F. Kronenberg, M. Auinger, E. Trenkwalder, K. Irsigler, G. Utermann, and H. Dieplinger Is apolipoprotein(a) a susceptibility gene for type I diabetes mellitus and related to long-term survival? Diabetologia 42 8 1999 1021 1024
325. D.D. Labudovic, K.N. Toseska, S.B. Alabakovska, and B. Todorova Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus Clin Biochem 36 7 2003 545 551
326. R. Christopher, K.M. Kailasanatha, D. Nagaraja, and M. Tripathi Case-control study of serum lipoprotein(a) and apolipoproteins A-I and B in stroke in the young Acta Neurol Scan 94 2 1996 127 130
327. G.F. Cao, Q.D. Yang, Y.H. Liu, H.W. Xu, and J. Xia Lipoprotein(a) and cerebral infarction in young adults Zhonghua Liu Xing Bing Xue Za Zhi 24 5 2003 397 400
328. M. Schillinger, H. Domanovits, M. Ignatescu, M. Exner, K. Bayegan, and R. Sedivy Lipoprotein(a) in patients with aortic aneurysmal disease J Vasc Surg 36 1 2002 25 30
329. G.M. Kostner, and A. Steinmetz Standardization of Lp(a) measurements Clin Genet 52 5 1997 393 397
330. G.M. Kostner, A. Ibovnik, H. Holzer, and H. Grillhofe Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard J Lipid Res 40 12 1999 2255 2263
331. J.R. Tate, N. Rifai, K. Berg, R. Couderc, F. Dati, and G.M. Kostner International Federation of Clinical Chemistry standardization project for the measurement of lipoprotein(a). Phase I. Evaluation of the analytical performance of lipoprotein(a) assay systems and commercial calibrators Clin Chem 44 8 Pt 1 1998 1629 1640
332. J.R. Tate, K. Berg, R. Couderc, F. Dati, G.M. Kostner, and S.M. Marcovina International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Standardization Project for the Measurement of Lipoprotein(a). Phase 2. Selection and properties of a proposed secondary reference material for lipoprotein(a) Clin Chem Lab Med 37 10 1999 949 958
333. C.L. Scholtz, A. Lingenhel, R. Hillermann, I.A. Stander, J.A. Kriek, and M.P. Marais Lipoprotein(a) determination and risk of cardiovascular disease in South African patients with familial hypercholesterolaemia S Afr Med J 90 4 2000 374 378
334. S.N. Pokrovsky, I.Yu. Adamova, O.Y. Afanasieva, and G.F. Benevolenskaya Immunosorbent for selective removal of lipoprotein(a) from human plasma: in vitro study Artif Organs 15 2 1991 136 140
335. S.N. Pokrovsky, A.V. Sussekov, O.I. Afanasieva, I.Y. Adamova, A.A. Lyakishev, and V.V. Kukharchuk Extracorporeal immunoadsorption for the specific removal of lipoprotein(a) (Lp(a) apheresis): preliminary clinical data Chem Phys Lipids 67-68 1994 323 330
336. S.N. Pokrovsky, M.V. Ezhov, L.N. Il'ina, O.I. Afanasieva, V.Y. Sinitsyn, and A.A. Shiriaev Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged men undergoing coronary artery bypass surgery J Thorac Cardiovasc Surg 126 4 2003 1071 1075
337. G. Luc, J.M. Bard, D. Arveiler, J. Ferrieres, A. Evans, and P. Amouyel PRIME Study Group Lipoprotein(a) as an predictor of coronary heart disease The Prime Study Atherosclerosis 163 2 2002 377 384
338. V. Solfrizzi, F. Panza, A.M. Colacicco, D. Capurso, A. D'Introno, and F. Torres Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > or = 65 years of age (The Italian Longitudinal Study on Aging, ILSA) Am J Cardiol 89 7 2002 825 829
339. M. Seed, K.L. Ayres, S.E. Humphries, and G.J. Miller Lipoprotein(a) as a predictor of myocardial infarction in middle-aged men Am J Med 110 1 2001 71 72